語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Rare diseases[electronic resource] :...
~
Ozguc, Meral.
Rare diseases[electronic resource] :integrative PPPM approach as the medicine of the future /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
616
書名/作者:
Rare diseases : integrative PPPM approach as the medicine of the future // edited by Meral Ozguc.
其他作者:
Ozguc, Meral.
出版者:
Dordrecht : : Springer Netherlands :, 2015.
面頁冊數:
xviii, 208 p. : : ill., digital ;; 24 cm.
Contained By:
Springer eBooks
標題:
Rare diseases.
標題:
Life Sciences.
標題:
Biological Techniques.
標題:
Cell Biology.
標題:
Pediatrics.
標題:
Metabolic Diseases.
ISBN:
9789401792141 (electronic bk.)
ISBN:
9789401792134 (paper)
內容註:
National Plans on rare diseases -- Biobanking for rare diseases Impact on personalized medicine -- Emerging Technologies for Gene Identification in Rare Diseases,- Personalized Medicine for Hereditary Deafness -- Mitochondrial Diseases -- Enzyme Replacement Therapy in Lysosomal Storage Diseases -- Complexity of Genotype-Phenotype Correlations in Mendelian Disorders: Lessons from Gaucher Disease -- Rare Cancers -- Adeno-Associated Virus Gene Therapy and its Application to the Prevention and Personalized Treatment of Rare Diseases -- Induced pluripotency for the study of disease mechanisms and cell therapy.
摘要、提要註:
This book focuses on predictive, preventative and personalised medicine (PPPM) and how it is related to the healthcare of rare diseases. Readers will discover how advanced rare diseases healthcare provides an excellent proof-of-principles for the personalisation of healthcare systems on a global scale. Chapters look at national plans for rare disease, at biobanking, gene identification, rare cancers, virus gene therapy , induced pluripotency for cell therapy amongst other topics. There is a chapter dedicated to personalised medicine for hereditary deafness, and another exploring the complexity of genotype-phenotype correlations. Specific diseases such as Fabry's, Gauchers and mitochondrial cytopathies are highlighted and we look at enzyme replacement therapy in lysosomal storage diseases. This work is part of a series, produced with the involvement of the European Association for Predictive, Preventive and Personalised Medicine. The series focusses on the concept of an integrative medical approach by PPPM. This volume is dedicated to all aspects related to the prediction, prevention and personalised treatments of rare diseases, and in doing so it explores developments relevant to all medical branches. The authors cover ethical considerations, the creation of a robust platform for professional communication, synergies with patient organisations, doctor-patient collaboration and a new philosophy of integrative medicine by PPPM. This volume serves as a reference source for scientific and medical centres in the field and can be used both at medical curricula and graduate level in the life sciences. Those who place a special emphasis on healthcare promotion and innovations intended to combat rare diseases, save the affected lives and enhance life quality will all find this book of great value.
電子資源:
http://dx.doi.org/10.1007/978-94-017-9214-1
Rare diseases[electronic resource] :integrative PPPM approach as the medicine of the future /
Rare diseases
integrative PPPM approach as the medicine of the future /[electronic resource] :edited by Meral Ozguc. - Dordrecht :Springer Netherlands :2015. - xviii, 208 p. :ill., digital ;24 cm. - Advances in predictive, preventive, and personalised medicine,v.62211-3495 ;. - Advances in predictive, preventive, and personalised medicine ;v.6..
National Plans on rare diseases -- Biobanking for rare diseases Impact on personalized medicine -- Emerging Technologies for Gene Identification in Rare Diseases,- Personalized Medicine for Hereditary Deafness -- Mitochondrial Diseases -- Enzyme Replacement Therapy in Lysosomal Storage Diseases -- Complexity of Genotype-Phenotype Correlations in Mendelian Disorders: Lessons from Gaucher Disease -- Rare Cancers -- Adeno-Associated Virus Gene Therapy and its Application to the Prevention and Personalized Treatment of Rare Diseases -- Induced pluripotency for the study of disease mechanisms and cell therapy.
This book focuses on predictive, preventative and personalised medicine (PPPM) and how it is related to the healthcare of rare diseases. Readers will discover how advanced rare diseases healthcare provides an excellent proof-of-principles for the personalisation of healthcare systems on a global scale. Chapters look at national plans for rare disease, at biobanking, gene identification, rare cancers, virus gene therapy , induced pluripotency for cell therapy amongst other topics. There is a chapter dedicated to personalised medicine for hereditary deafness, and another exploring the complexity of genotype-phenotype correlations. Specific diseases such as Fabry's, Gauchers and mitochondrial cytopathies are highlighted and we look at enzyme replacement therapy in lysosomal storage diseases. This work is part of a series, produced with the involvement of the European Association for Predictive, Preventive and Personalised Medicine. The series focusses on the concept of an integrative medical approach by PPPM. This volume is dedicated to all aspects related to the prediction, prevention and personalised treatments of rare diseases, and in doing so it explores developments relevant to all medical branches. The authors cover ethical considerations, the creation of a robust platform for professional communication, synergies with patient organisations, doctor-patient collaboration and a new philosophy of integrative medicine by PPPM. This volume serves as a reference source for scientific and medical centres in the field and can be used both at medical curricula and graduate level in the life sciences. Those who place a special emphasis on healthcare promotion and innovations intended to combat rare diseases, save the affected lives and enhance life quality will all find this book of great value.
ISBN: 9789401792141 (electronic bk.)
Standard No.: 10.1007/978-94-017-9214-1doiSubjects--Topical Terms:
602918
Rare diseases.
LC Class. No.: RC48.8
Dewey Class. No.: 616
Rare diseases[electronic resource] :integrative PPPM approach as the medicine of the future /
LDR
:03529nam a2200349 a 4500
001
424766
003
DE-He213
005
20150605161922.0
006
m d
007
cr nn 008maaau
008
151119s2015 ne s 0 eng d
020
$a
9789401792141 (electronic bk.)
020
$a
9789401792134 (paper)
024
7
$a
10.1007/978-94-017-9214-1
$2
doi
035
$a
978-94-017-9214-1
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC48.8
072
7
$a
PS
$2
bicssc
072
7
$a
PDN
$2
bicssc
072
7
$a
SCI008000
$2
bisacsh
072
7
$a
SCI043000
$2
bisacsh
082
0 4
$a
616
$2
23
090
$a
RC48.8
$b
.R221 2015
245
0 0
$a
Rare diseases
$h
[electronic resource] :
$b
integrative PPPM approach as the medicine of the future /
$c
edited by Meral Ozguc.
260
$a
Dordrecht :
$b
Springer Netherlands :
$b
Imprint: Springer,
$c
2015.
300
$a
xviii, 208 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Advances in predictive, preventive, and personalised medicine,
$x
2211-3495 ;
$v
v.6
505
0
$a
National Plans on rare diseases -- Biobanking for rare diseases Impact on personalized medicine -- Emerging Technologies for Gene Identification in Rare Diseases,- Personalized Medicine for Hereditary Deafness -- Mitochondrial Diseases -- Enzyme Replacement Therapy in Lysosomal Storage Diseases -- Complexity of Genotype-Phenotype Correlations in Mendelian Disorders: Lessons from Gaucher Disease -- Rare Cancers -- Adeno-Associated Virus Gene Therapy and its Application to the Prevention and Personalized Treatment of Rare Diseases -- Induced pluripotency for the study of disease mechanisms and cell therapy.
520
$a
This book focuses on predictive, preventative and personalised medicine (PPPM) and how it is related to the healthcare of rare diseases. Readers will discover how advanced rare diseases healthcare provides an excellent proof-of-principles for the personalisation of healthcare systems on a global scale. Chapters look at national plans for rare disease, at biobanking, gene identification, rare cancers, virus gene therapy , induced pluripotency for cell therapy amongst other topics. There is a chapter dedicated to personalised medicine for hereditary deafness, and another exploring the complexity of genotype-phenotype correlations. Specific diseases such as Fabry's, Gauchers and mitochondrial cytopathies are highlighted and we look at enzyme replacement therapy in lysosomal storage diseases. This work is part of a series, produced with the involvement of the European Association for Predictive, Preventive and Personalised Medicine. The series focusses on the concept of an integrative medical approach by PPPM. This volume is dedicated to all aspects related to the prediction, prevention and personalised treatments of rare diseases, and in doing so it explores developments relevant to all medical branches. The authors cover ethical considerations, the creation of a robust platform for professional communication, synergies with patient organisations, doctor-patient collaboration and a new philosophy of integrative medicine by PPPM. This volume serves as a reference source for scientific and medical centres in the field and can be used both at medical curricula and graduate level in the life sciences. Those who place a special emphasis on healthcare promotion and innovations intended to combat rare diseases, save the affected lives and enhance life quality will all find this book of great value.
650
0
$a
Rare diseases.
$3
602918
650
1 4
$a
Life Sciences.
$3
463509
650
2 4
$a
Biological Techniques.
$3
464355
650
2 4
$a
Cell Biology.
$3
463594
650
2 4
$a
Pediatrics.
$3
381606
650
2 4
$a
Metabolic Diseases.
$3
465858
700
1
$a
Ozguc, Meral.
$3
602916
710
2
$a
SpringerLink (Online service)
$3
463450
773
0
$t
Springer eBooks
830
0
$a
Advances in predictive, preventive, and personalised medicine ;
$v
v.6.
$3
602917
856
4 0
$u
http://dx.doi.org/10.1007/978-94-017-9214-1
950
$a
Medicine (Springer-11650)
筆 0 讀者評論
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-94-017-9214-1
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入